Clinical applications of SPECT imaging. An ECRI technology assessment

Area of Science:

• Medical Imaging
• Nuclear Medicine
• Radiopharmaceuticals

Background:

• Single Photon Emission Computed Tomography (SPECT) is an advanced nuclear medicine imaging technique.
• SPECT provides three-dimensional radionuclide imaging, regional blood flow data, and organ volume measurements.
• Interest in SPECT has grown due to research, instrumentation improvements, and new radiopharmaceuticals.

Purpose of the Study:

• To evaluate the current and potential applications of SPECT in clinical settings.
• To assess the impact of SPECT on patient care outcomes and its cost-effectiveness.
• To guide hospitals in decisions regarding SPECT acquisition.

Main Methods:

• Review of existing research on SPECT applications in cardiac, liver, bone, and neurological imaging.
• Analysis of SPECT's advantages over planar imaging and other techniques.
• Consideration of factors influencing SPECT acquisition decisions, including cost and existing infrastructure.

Main Results:

• SPECT demonstrates recognized applications in cardiac, liver, and bone imaging, offering improvements over planar scanning.
• Preliminary research suggests significant potential for SPECT in neurology, particularly in measuring brain physiology.
• Limited data currently exists on SPECT's impact on patient outcomes and its relative cost-effectiveness.

Conclusions:

• SPECT offers significant advantages in diagnostic imaging, with expanding applications.
• Further research is needed to establish the clinical and cost-effectiveness of SPECT, impacting acquisition decisions.
• Hospitals should consider upgrading existing equipment to facilitate future SPECT integration and monitor ongoing research.